Detalhe da pesquisa
1.
Scientific and Regulatory Policy Committee Points to Consider: Fixation, Trimming, and Sectioning of Nonrodent Eyes and Ocular Tissues for Examination in Ocular and General Toxicity Studies.
Toxicol Pathol
; 50(2): 235-251, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34693851
2.
Selected Aspects of Ocular Toxicity Studies With a Focus on High-Quality Pathology Reports: A Pathology/Toxicology Consultant's Perspective.
Toxicol Pathol
; 49(3): 673-699, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32815474
3.
Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular.
Int J Toxicol
; 37(1): 4-27, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29264927
4.
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials.
Regul Toxicol Pharmacol
; 70(1): 413-29, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078890
5.
Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologist.
Toxicol Pathol
; 41(8): 1159-69, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23531793
6.
Alternative mouse models for carcinogenicity assessment: industry use and issues with pathology interpretation.
Toxicol Pathol
; 38(1): 43-50, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19915137
7.
Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations.
Toxicol Pathol
; 38(4): 522-53, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20472697
8.
Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
Toxicol Pathol
; 36(1): 49-62, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18337221
9.
Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
J Ocul Pharmacol Ther
; 21(1): 36-43, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15718826
10.
Maggot therapy in "lower-extremity hospice" wound care: fewer amputations and more antibiotic-free days.
J Am Podiatr Med Assoc
; 95(3): 254-7, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15901812
11.
Clinical efficacy of the first metatarsophalangeal joint arthroplasty as a curative procedure for hallux interphalangeal joint wounds in patients with diabetes.
Diabetes Care
; 26(12): 3284-7, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14633815
12.
Outcomes of hyaluronan therapy in diabetic foot wounds.
Diabetes Res Clin Pract
; 59(2): 123-7, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12560161
13.
Use of a maggot motility index to evaluate survival of therapeutic larvae.
J Am Podiatr Med Assoc
; 94(4): 353-5, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15265993
14.
Maggot debridement therapy: a primer.
J Am Podiatr Med Assoc
; 92(7): 398-401, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12122127
15.
Technique for fabrication of an "instant total-contact cast" for treatment of neuropathic diabetic foot ulcers.
J Am Podiatr Med Assoc
; 92(7): 405-8, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12122129
16.
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027.
Am J Ophthalmol
; 150(1): 33-39.e2, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20609706
17.
5 questions--and answers--about maggot debridement therapy.
Adv Skin Wound Care
; 16(2): 99-102, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12690234